CDC20siRNA and paclitaxel co-loaded nanometric liposomes of a nipecotic acid-derived cationic amphiphile inhibit xenografted neuroblastoma

Nanoscale ◽  
2017 ◽  
Vol 9 (3) ◽  
pp. 1201-1212 ◽  
Author(s):  
Sukanya Bhunia ◽  
Vegesna Radha ◽  
Arabinda Chaudhuri
2018 ◽  
Vol 14 (4) ◽  
pp. 409-426 ◽  
Author(s):  
Ankit Seth ◽  
Piyoosh A. Sharma ◽  
Avanish Tripathi ◽  
Priyanka K. Choubey ◽  
Pavan Srivastava ◽  
...  

Drug Research ◽  
2020 ◽  
Author(s):  
Meenakshi Dhanawat ◽  
Sumeet Gupta ◽  
Dinesh Kumar Mehta ◽  
Rina Das

Nipecotic acid is considered to be one of the most potent inhibitors of neuronal and glial-aminobutyric acid (GABA) uptake in vitro. Due to its hydrophilic nature, nipecotic acid does not readily cross the blood-brain barrier (BBB). Large neutral amino acids (LAT1)-knotted nipecotic acid prodrug was designed and synthesized with the aim to enhance the BBB permeation by the use of carrier-mediated transport. The synthesized prodrug was tested in animal models of Pentylenetetrazole (PTZ)-induced convulsions in mice. Further pain studies were carried out followed by neurotoxicity estimation by writhing and rota-rod test respectively. HPLC data suggests that the synthesized prodrug has improved penetration through BBB. Nipecotic acid-L-serine ester prodrug with considerable anti-epileptic activity, and the ability to permeate the BBB has been successfully synthesized. Graphical Abstract.


2014 ◽  
Vol 444 ◽  
pp. 7-14 ◽  
Author(s):  
Elżbieta Bartoszak-Adamska ◽  
Zofia Dega-Szafran ◽  
Anna Komasa ◽  
Mirosław Szafran

1992 ◽  
Vol 580 (1-2) ◽  
pp. 311-316 ◽  
Author(s):  
Ingrid Sundman ◽  
Ulrika Lernmark ◽  
Jan Marcusson

1992 ◽  
Vol 609 (1-2) ◽  
pp. 187-193 ◽  
Author(s):  
Z. Feng ◽  
R. Gollamudi ◽  
G. Han ◽  
Y. Tang ◽  
D.W. Armstrong

1990 ◽  
Vol 68 (9) ◽  
pp. 1194-1199 ◽  
Author(s):  
U. Ebert ◽  
K. Krnjević

A new potent, blood–brain barrier permeable γ-aminobutyric acid (GABA) uptake blocker, 1-[2-[bis[4-(trifluoromethyl)-phenyl]methoxy]ethyl]-1,2,5,6-tetrahydro-3-pyridinecarboxylic acid (CI-966) was administered systemically by i.p. injection (5 mg/kg) in Sprague–Dawley rats under urethane anaesthesia. Twenty to thirty minutes after injection there was a highly variable, but overall significant, enhancement of the inhibition of hippocampal population spikes by GABA applied by microiontophoresis in the CA1 region. Like the effect of nipecotic acid (applied locally by iontophoresis), the potentiation by CI-966 was clearest when GABA was applied in or near the stratum pyramidale where its action normally is weakest and shows the most pronounced fading. This change in GABA potency is most simply explained by a reduction in GABA uptake.Key words: GABA, muscimol, nipecotic acid, GABA-uptake blocker, epilepsy.


1997 ◽  
Vol 331 (2-3) ◽  
pp. 139-144 ◽  
Author(s):  
Gabor Juhász ◽  
Katalin A Kékesi ◽  
Gabriella Nyitrai ◽  
Arpád Dobolyi ◽  
Povl Krogsgaard-Larsen ◽  
...  

Author(s):  
MEIR BIALER ◽  
BASHIER KADRY ◽  
ALI ABDUL-HAI ◽  
ABDULLAH HAJ-YEHIA ◽  
JEFF STERLING ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document